BALAXI PHARMACEUTICALS LIMITED — Others, 30-12-2024: Trading Window

Balaxi Pharmaceuticals Limited has announced the closure of its trading window for designated persons and their immediate relatives from January 1, 2025, until 48 hours after the announcement of the financial results for the third quarter. The specific date for the board meeting to consider these results will be communicated later. This move aligns with best practices in corporate governance and aims to prevent insider trading. Investors might view this closure as a sign of the company’s commitment to transparency, which could foster a positive outlook among shareholders as the results are anticipated.